Mari-Ann Wallander

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 2

Top Topics

Venous Thromboembolism

Clinical Practice

Skeletal Muscle

Breast Cancer Risk

Top Venues

Expert opinion on drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Luis Alberto García-Rodríguez, Mari-Ann Wallander, Leif Friberg, Ana Ruigómez, Cristina Rebordosa, Irene D Bezemer, Ron M C Herings, Saad Shakir, Alison Evans, Miranda Davies, Kiliana Suzart-Woischnik, Pareen Vora, Yanina Balabanova, Montse Soriano Gabarró, Gunnar Brobert
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice. Expert opinion on drug safety 19 (11) (2020)
Annika Bardel, Mari-Ann Wallander, Thorne Wallman, Annika Rosengren, Saga Johansson, Henry Eriksson, Kurt Svärdsudd
Age and sex related self-reported symptoms in a general population across 30 years: Patterns of reporting and secular trend. PloS one 14 (2) (2019)